Sarepta Therapeutics (SRPT) PT Raised to $185 at BofA Securities on SRP-9001 approval
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $185.00 (from $176.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
